NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE268838 Query DataSets for GSE268838
Status Public on Jun 05, 2024
Title Arachidonic acid mobilization and peroxidation promote microglial dysfunction in Aβ pathology
Organism Mus musculus
Experiment type Expression profiling by high throughput sequencing
Summary Aberrant increase of arachidonic acid (ARA) has long been implicated in the pathology of Alzheimer's disease (AD), while the underlying causal mechanism remains unclear. In this study, we revealed a link between ARA mobilization and microglial dysfunction in Aβ pathology. Lipidomic analysis of primary microglia from AppNL-GF mice showed a marked increase in free ARA and lysophospholipids (LPLs) along with a decrease in ARA-containing phospholipids, suggesting increased ARA release from phospholipids (PLs). To manipulate ARA-containing PLs in microglia, we genetically deleted Lysophosphatidylcholine Acyltransferase 3 (Lpcat3), the main enzyme catalyzing the incorporation of ARA into PLs. Loss of microglial Lpcat3 reduced the levels of ARA-containing phospholipids, free ARA and LPLs, leading to a compensatory increase in monounsaturated fatty acid (MUFA)-containing PLs in the AppNL-GF mice. Notably, the reduction of ARA in microglia significantly ameliorated oxidative stress and inflammatory responses while enhancing the phagocytosis of Aβ plaques and promoting the compaction of Aβ deposits. Mechanistically, sc-RNA seq suggested that LPCAT3 deficiency facilitates phagocytosis by facilitating de novo lipid synthesis while protecting microglia from oxidative damage. Collectively, our study reveals a novel mechanistic link between ARA mobilization and microglial dysfunction in AD. Lowering brain ARA levels through pharmacological or dietary interventions may be a potential therapeutic strategy to slow down AD progression.
 
Overall design To manipulate ARA-containing PLs in microglia, we genetically deleted Lysophosphatidylcholine Acyltransferase 3 (Lpcat3), the main enzyme catalyzing the incorporation of ARA into PLs. We analyzed the impact of Lpcat3 deletion on microgllia response to Aβ pathology using immunostaining, bulk and single-cell RNA seq, and flow cytometry.
 
Contributor(s) Lin D, Gao J
Citation(s) 38866484
NIH grant(s)
Grant ID Grant title Affiliation Name
R01 AG073310 Targeting IDOL-ApoE receptor pathway in Alzheimer's disease OHIO STATE UNIVERSITY Jie Gao
Submission date May 31, 2024
Last update date Sep 04, 2024
Contact name Jie Gao
E-mail(s) Jie.Gao@osumc.edu
Organization name The Ohio State University
Department The Department of Neuroscience
Lab Gao Lab
Street address 460 W. 12th Ave
City Columbus
State/province OH
ZIP/Postal code 43210
Country USA
 
Platforms (1)
GPL17021 Illumina HiSeq 2500 (Mus musculus)
Samples (13)
GSM8301015 Hippocampus from AppNL-G-F; Lpcat3 f/f; vav1-CRE, 9 mo; 3283
GSM8301016 Hippocampus from AppNL-G-F; Lpcat3 f/f; vav1-CRE, 9 mo; 3284
GSM8301017 Hippocampus from AppNL-G-F; Lpcat3 f/f; vav1-CRE, 9 mo; 3285
Relations
BioProject PRJNA1118825

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE268838_ProcessedData_CountMatrix.txt.gz 940.3 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap